Abstract
Diuretics are commonly used to control edema across various clinical fields. Diuretics inhibit sodium reabsorption in specific renal tubules, resulting in increased urinary sodium and water excretion. Loop diuretics are the most potent diuretics. In this article, we review five important aspects of loop diuretics, in particular furosemide, which must be considered when prescribing this medicine: (1) oral versus intravenous treatment, (2) dosage, (3) continuous versus bolus infusion, (4) application in chronic kidney disease patients, and (5) side effects. The bioavailability of furosemide differs between oral and intravenous therapy. Additionally, the threshold and ceiling doses of furosemide differ according to the particular clinical condition of the patient, for example in patients with severe edema or chronic kidney disease. To maximize the efficiency of furosemide, a clear understanding of how the mode of delivery will impact bioavailability and the required dosage is necessary.
| Original language | English |
|---|---|
| Pages (from-to) | 17-21 |
| Number of pages | 5 |
| Journal | Electrolyte and Blood Pressure |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2015 Jan 1 |
| Externally published | Yes |
Fingerprint
Keywords
- Chronic kidney disease
- Furosemide
- Loop diuretics
ASJC Scopus subject areas
- Internal Medicine
- Physiology
- Cardiology and Cardiovascular Medicine
Cite this
Loop diuretics in clinical practice. / Oh, Se Won; Han, Sang Youb.
In: Electrolyte and Blood Pressure, Vol. 13, No. 1, 01.01.2015, p. 17-21.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Loop diuretics in clinical practice
AU - Oh, Se Won
AU - Han, Sang Youb
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Diuretics are commonly used to control edema across various clinical fields. Diuretics inhibit sodium reabsorption in specific renal tubules, resulting in increased urinary sodium and water excretion. Loop diuretics are the most potent diuretics. In this article, we review five important aspects of loop diuretics, in particular furosemide, which must be considered when prescribing this medicine: (1) oral versus intravenous treatment, (2) dosage, (3) continuous versus bolus infusion, (4) application in chronic kidney disease patients, and (5) side effects. The bioavailability of furosemide differs between oral and intravenous therapy. Additionally, the threshold and ceiling doses of furosemide differ according to the particular clinical condition of the patient, for example in patients with severe edema or chronic kidney disease. To maximize the efficiency of furosemide, a clear understanding of how the mode of delivery will impact bioavailability and the required dosage is necessary.
AB - Diuretics are commonly used to control edema across various clinical fields. Diuretics inhibit sodium reabsorption in specific renal tubules, resulting in increased urinary sodium and water excretion. Loop diuretics are the most potent diuretics. In this article, we review five important aspects of loop diuretics, in particular furosemide, which must be considered when prescribing this medicine: (1) oral versus intravenous treatment, (2) dosage, (3) continuous versus bolus infusion, (4) application in chronic kidney disease patients, and (5) side effects. The bioavailability of furosemide differs between oral and intravenous therapy. Additionally, the threshold and ceiling doses of furosemide differ according to the particular clinical condition of the patient, for example in patients with severe edema or chronic kidney disease. To maximize the efficiency of furosemide, a clear understanding of how the mode of delivery will impact bioavailability and the required dosage is necessary.
KW - Chronic kidney disease
KW - Furosemide
KW - Loop diuretics
UR - http://www.scopus.com/inward/record.url?scp=84942751165&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84942751165&partnerID=8YFLogxK
U2 - 10.5049/EBP.2015.13.1.17
DO - 10.5049/EBP.2015.13.1.17
M3 - Review article
AN - SCOPUS:84942751165
VL - 13
SP - 17
EP - 21
JO - Electrolyte and Blood Pressure
JF - Electrolyte and Blood Pressure
SN - 1738-5997
IS - 1
ER -